Position
Chief Executive Officer
Company
CERo Therapeutics Holdings
South San FranciscoOtherBiotechnologyHealth CareTherapeuticsDescription
CERo Therapeutics Holdings, Inc. announces the appointment of Chris Ehrlich as CEO. Chris Ehrlich brings significant biotechnology industry, business development, venture capital, and investment banking experience to the role.
Quick answer
CERo Therapeutics, Inc. Appoints Chris Ehrlich as CEO (December 6, 2024). CERo Therapeutics Holdings is based in South San Francisco, California, United States.
- Who is the new Chief Executive Officer at CERo Therapeutics Holdings?
- CERo Therapeutics Holdings named Chris Ehrlich Chief Executive Officer, announced December 6, 2024.
- What did CERo Therapeutics Holdings announce on December 6, 2024?
- CERo Therapeutics Holdings, Inc. announces the appointment of Chris Ehrlich as CEO. Chris Ehrlich brings significant biotechnology industry, business development, venture capital, and investment banking experience to the role.
- What does CERo Therapeutics Holdings do?
- CERo Therapeutics Holdings, Inc. is an innovative immunotherapy company focused on advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer.
- Where is CERo Therapeutics Holdings based?
- CERo Therapeutics Holdings is based in South San Francisco, California, United States.
- Which similar companies made leadership changes around the same time?
- Beam Therapeutics Inc. (December 6, 2024), Nanoscope Therapeutics (December 6, 2024), Franklin Biolabs (December 4, 2024) and ITF Therapeutics (December 4, 2024) also announced leadership changes within 45 days of CERo Therapeutics Holdings.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Beam Therapeutics Inc. Appoints Sravan K. Emany as Chief Financial Officer (December 6, 2024)
- Nanoscope Therapeutics Hires Ray Kaczmarek as Chief Technology and Manufacturing Officer (December 6, 2024)
- Franklin Biolabs Names Vatsala Naageshwaran as Chief Executive Officer (December 4, 2024)
- ITF Therapeutics Appoints Erica L. Monaco as Chief Operating Officer (December 4, 2024)
- Incendia Therapeutics Appoints Bradford Smith as Chief Financial Officer (December 3, 2024)
- Nouscom Appoints Eckhard Niemeier as Chief Business Officer (December 3, 2024)
Who to call at CERo Therapeutics Holdings, and when
A new leader at CERo Therapeutics Holdings brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day CERo Therapeutics Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CERo Therapeutics Holdings, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CERo Therapeutics Holdings. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CERo Therapeutics Holdings changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CERo Therapeutics Holdings changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.